Live
·
Open questions in longevity research
eternal
search
Powered by
Overview
▾
A
Home
The whole field on one page
B
Directions
Eight ways to fight ageing, each with its companies, projects and people
C
The questions we answer
One question at a time, answered in public
Analysis
▾
A
Companies
Rated on the evidence behind their claims
B
Projects
Scored on science, breakthrough odds and the investment case
C
People
Who moves the field, and on what grounds
D
Funds
Who funds the field and how
E
Preservation
Cryonics and biostasis companies rated
Research
▾
A
Questions
Gaps in the science, each with its rival hypotheses
B
Hypotheses
Every published hypothesis, cut by the gap it closes
C
Experiments
The tests that would decide between rivals
D
Protocols
Study designs written out in full
E
The lab
Run the engine and watch it work
F
Method
How the research engine reads the literature
Forecasts
▾
A
Predictions
Open forecasts, each with a resolve date
B
Leaderboard
Whose forecasts have held up
Funding
▾
A
Grants
Verified deadlines and submission links
B
Events
Conferences and calls with verified dates
Materials
▾
A
News
What moved in the field
B
Journal
Daily dispatches from the desk
C
Essays
Positions argued in public, under a name
D
Posters
One sheet per scientific argument
E
Presentations
Decks that answer one question each
F
Dictionary
The terms the site uses, defined
About
Sign in
Eternal Search · Ratings · Project Ratings
Bioinformation
Computational biology, omics, and AI applied to biology.
All sections
#
Overall
Project
Sci / Brk / Inv
1
52.6
OpenDrugs
OpenDrugs appears to be an AI-enabled, evidence-first longevity compound database and research workspace built by OpenLongevity for researchers, with search, comparison, visualization, research boards, and candidate-generation workflows across aging-related substances rather than a therapeutic program of its own. The strongest project-specific evidence supports platform scope, architecture, data-source integration, and provenance features, but not outcome validation: the project claims 3.1K indexed substances, 27 synced open sources, 13 animal models, version 2.4 stable dated 2026-05-07, and auditable evidence scoring, while also disclosing that it is a triage/research tool rather than a regulatory or clinical-decision system and showing at least one notable possible data gap via a reported metric of 0 biological targets linked to substances and pathways.
Sci
55.7
Brk
49.4
Inv
52.0
53%